|
|
||||||||
University of California, San Francisco, School of Medicine, San Francisco, CA.
For patients with chronic intractable headache, we compared a new treatment and a traditional one. Fifty-five patients (36 dependent on ergotamine, analgesics, diazepam, or corticosteroids) were given IV dihydroergotamine (DHE) and metoclopramide every 8 hours. Fifty-four age- and sex-matched patients (38 drug-dependent) were given diazepam intravenously every 8 hours. Forty-nine of the 55 DHE-treated patients became headache-free within 48 hours, and 39 of them sustained benefits in a mean follow-up of 16 months. In contrast, 7 diazepam-treated patients became free of headache within 3 to 6 days, and 31 had improved somewhat in 10 days. Repetitive IV DHE helps to terminate cycles of intractable migraine.
Address correspondence and reprint requests to Dr. Raskin, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.
Accepted for publication November 6, 1985.
This article has been cited by other articles:
![]() |
T. Tucker A Practical Approach to Headache Treatment Journal of Pharmacy Practice, April 1, 2007; 20(2): 123 - 136. [Abstract] [PDF] |
||||
![]() |
A. D. Hershey and P. K. Winner Pediatric Migraine: Recognition and Treatment J Am Osteopath Assoc, April 1, 2005; 105(4_suppl): 2S - 8S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Goadsby and C. Boes CHRONIC DAILY HEADACHE J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(90002): ii2 - 5. [Full Text] |
||||
![]() |
Z. Katsarava, G. Fritsche, M. Muessig, H.C. Diener, and V. Limmroth Clinical features of withdrawal headache following overuse of triptans and other headache drugs Neurology, November 13, 2001; 57(9): 1694 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J GOADSBY A triptan too far? J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 143 - 147. [Full Text] [PDF] |
||||
![]() |
K.M.A. Welch Drug Therapy of Migraine N. Engl. J. Med., November 11, 1993; 329(20): 1476 - 1483. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |